Antibiotics for spontaneous bacterial peritonitis in cirrhotic patients.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Cochrane Database of Systematic Reviews

• Publication date

  2009-01-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/14651858.CD002232.pub2PMID 19160207PMCID PMC7100568
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bacterial DNA in patients with cirrhosis and noninfected ascites mimics the soluble immune response established in patients with spontaneous bacterial peritonitis

  2008cited by this paper
• Spontaneous bacterial peritonitis and bacterascites prevalence in asymptomatic cirrhotic outpatients undergoing large‐volume paracentesis

  2008cited by this paper
• Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

  2008cited by this paper
• Association Between Model for End-Stage Liver Disease and Spontaneous Bacterial Peritonitis

  2007cited by this paper
• Pathophysiology of ascites and dilutional hyponatremia: contemporary use of aquaretic agents.

  2007cited by this paper
• Renal failure and bacterial infections in patients with cirrhosis: Epidemiology and clinical features

  2007cited by this paper
• Review article: management of ascites and associated complications in patients with cirrhosis

  2007cited by this paper
• The molecular basis of susceptibility to infection in liver cirrhosis.

  2007cited by this paper
• Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost

  2006cited by this paper
• Spontaneous bacterial peritonitis in liver cirrhosis: Treatment and prophylaxis

  2005cited by this paper
• Single daily amikacin versus cefotaxime in the short-course treatment of spontaneous bacterial peritonitis in cirrhotics.

  2005cited by this paper
• Comparison of cefotaxime and ofloxacin in treatment of spontaneous bacterial peritonitis.

  2004cited by this paper
• LITERATURE SEARCHING FOR RANDOMIZED CONTROLLED TRIALS USED IN COCHRANE REVIEWS: RAPID VERSUS EXHAUSTIVE SEARCHES

  2003cited by this paper
• Oral ciprofloxacin versus intravenous cefotaxime and ceftriaxone in the treatment of spontaneous bacterial peritonitis.

  2003cited by this paper
• Spontaneous bacterial peritonitis (SBP): clinical, laboratory, and prognostic features. A single-center experience.

  2002cited by this paper
• Alcoholic hepatitis - glucocorticosteriods or not?

  2002cited by this paper
• Five days of ceftriaxone to treat spontaneous bacterial peritonitis in cirrhotic patients

  2002cited by this paper
• Bacterial infections in cirrhosis: Epidemiological changes with invasive procedures and norfloxacin prophylaxis

  2002cited by this paper
• Reported Methodologic Quality and Discrepancies between Large and Small Randomized Trials in Meta-Analyses

  2001cited by this paper
• Spontaneous bacterial peritonitis—in-hospital mortality, predictors of survival, and health care costs from 1988 to 1998

  2001cited by this paper
• Spontaneous bacterial peritonitis - In-hospital mortality, predictors of survival, and health care costs from 1988 to 1998

  2001cited by this paper
• Antibiotics for spontaneous bacterial peritonitis in cirrhotics.

  2001cited by this paper
• Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients.

  2000cited by this paper
• Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club.

  2000cited by this paper
• Oral ciprofloxacin after a short course of intravenous ciprofloxacin in the treatment of spontaneous bacterial peritonitis: results of a multicenter, randomized study.

  2000cited by this paper
• Evaluation of the therapeutic effect of pefloxacin in comparison with ampicillin and gentamicin in cirrhotic patients with spontaneous bacterial peritonitis.

  1998cited by this paper
• Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

  1998cited by this paper
• Cefalosporina oral para o tratamento de peritonite bacteriana espontanea nao complicada na cirrose hepatica: um estudo prospectivo de 38 casos

  1997cited by this paper
• Bias in meta-analysis detected by a simple, graphical test

  1997cited by this paper
• Spontaneous ascitic infection in different cirrhotic groups: prevalence, risk factors and the efficacy of cefotaxime therapy

  1997cited by this paper
• A prospective randomized trial of ceftazidime versus netilmicin plus mezlocillin in the empirical therapy of presumed sepsis in cirrhotic patients

  1997cited by this paper
• Spontaneous Bacterial Peritonitis

  1997cited by this paper
• Improving the quality of reporting of randomized controlled trials. The CONSORT statement.

  1996cited by this paper
• Cefotaxime in the treatment of spontaneous bacterial peritonitis

  1996cited by this paper
• Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis.

  1996cited by this paper
• Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis

  1996cited by this paper
• The CONSORT Statement

  1996cited by this paper
• Experience with cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis.

  1995cited by this paper
• Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials.

  1995cited by this paper
• Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: Results of a prospective, randomized, multicenter study

  1995cited by this paper
• Spontaneous bacterial peritonitis: an update on evaluation, management, and prevention.

  1994cited by this paper
• Randomized trial comparing ceftriaxone with cefonicid for treatment of spontaneous bacterial peritonitis in cirrhotic patients

  1993cited by this paper
• Short-term prognosis of cirrhotics with spontaneous bacterial peritonitis: multivariate study.

  1993cited by this paper
• Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis. A randomized controlled study of 100 patients.

  1991cited by this paper
• Aztreonam vs. cefotaxime in the treatment of gram‐negative spontaneous peritonitis in cirrhotic patients

  1991cited by this paper
• Polymorphonuclear cell count response and duration of antibiotic therapy in spontaneous bacterial peritonitis

  1989cited by this paper
• [Can septicemia and ascitic fluid infections in cirrhotic patients be treated by the oral route alone?].

  1989cited by this paper
• Use of ceftriaxone in the treatment of bacterial infections in cirrhotic patients.

  1989cited by this paper
• Intravenous ciprofloxacin and ceftazidime in serious infections. A prospective, controlled clinical trial with third-party blinding.

  1989cited by this paper
• QT interval prolongation.

  1985cited by this paper
• Cefotaxime is more effective than is ampicillin‐tobramycin in cirrhotics with severe infections

  1985cited by this paper

• Frequency of Asymptomatic Spontaneous Bacterial Peritonitis in Patients with Chronic Liver Disease and Ascites

  2024cites this paper
• Das aktute Abdomen auf der Intensivstation

  2024cites this paper
• Das aktute Abdomen auf der Intensivstation

  2024cites this paper
• Culture-Negative Fibrinous Peritonitis in a Postpartum Female

  2023cites this paper
• Spontaneous bacterial peritonitis caused by Campylobacter Coli in cirrhotic patient

  2020cites this paper
• Liver Cirrhosis Complications Management At The Emergency Department.

  2020cites this paper
• Aktualisierte S2k-Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) „Komplikationen der Leberzirrhose“

  2019cites this paper
• Chapter 80 : Hepatic Disorders

  2019cites this paper
• The lack of guidelines and government policies for regulating nonprescription sale of antibiotics and its medical consequences.

  2019cites this paper
• Antibiotika und der Gastrointestinaltrakt – Update 2019

  2019cites this paper
• Aktualisierte S2k-Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) „Komplikationen der Leberzirrhose“

  2019cites this paper
• Treatment of Spontaneous Bacterial Peritonitis

  2019cites this paper
• The emergency medicine evaluation and management of the patient with cirrhosis

  2018influential citation
• Antibiotic treatment for spontaneous bacterial peritonitis in people with decompensated liver cirrhosis: a network meta-analysis

  2018cites this paper
• Antibiotic treatment for spontaneous bacterial peritonitis in people with decompensated liver cirrhosis: a network meta-analysis.

  2018cites this paper
• Classification and Principals of Treatment

  2018cites this paper
• The Human Gut Microbiome in Liver Diseases

  2017cites this paper
• Spontaneous Bacterial Peritonitis (SBP)

  2017cites this paper
• Das akute Abdomen auf der Intensivstation

  2017cites this paper
• Antimikrobielle und antiinfektiöse Maßnahmen

  2016cites this paper
• Das akute Abdomen auf der Intensivstation

  2016cites this paper
• The Emergency Medicine Approach to the Decompensating Cirrhotic Patient

  2016cites this paper
• Portal hypertensive gastropathy: A systematic review of the pathophysiology, clinical presentation, natural history and therapy.

  2016cites this paper
• Update on Spontaneous Bacterial Peritonitis

  2015cites this paper
• Antibiotika und der Gastrointestinaltrakt

  2015cites this paper
• Update on a proper use of systemic fluoroquinolones in adult patients (ciprofloxacin, levofloxacin, moxifloxacin, norfloxacin, ofloxacin, pefloxacin. SPILF.).

  2015cites this paper
• Antibiotikatherapie intraabdomineller Infektionen im Zeitalter der Multiresistenz

  2015cites this paper
• The End-Organ Impairment in Liver Cirrhosis: Appointments for Critical Care

  2012cites this paper
• Abdominal Wall, Umbilicus, Peritoneum, Mesenteries, Omentum, and Retroperitoneum

  2012cites this paper
• Infectious Complications of Acute and Chronic Liver Disease

  2012cites this paper
• Einsatz von Antibiotika und Antimykotika in Prophylaxe und Therapie bei großen viszeralchirurgischen Eingriffen

  2011cites this paper
• Leitliniengerechte Diagnostik und Therapie des Aszites

  2011cites this paper
• S3-Leitlinie „Aszites, spontan bakterielle Peritonitis, hepatorenales Syndrom”

  2011cites this paper
• Spontaneous bacterial peritonitis.

  2011cites this paper
• CHAPTER 39 – Abdominal and other surgical infections

  2010cites this paper
• Ascites

  2010cites this paper
• Gram's stain of peritoneal fluid is rarely helpful in the evaluation of the ascites patient.

  2009cites this paper
• Refractory Ascites: Pathogenesis, Clinical Impact, and Management.

  2009cites this paper
• Antibiotic prophylaxis for spontaneous bacterial peritonitis in cirrhotic patients with ascites, without gastro-intestinal bleeding.

  2009cites this paper
• S3-Leitlinie „ Aszites, spontan bakterielle Peritonitis, hepatorenales Syndrom “ German S 3-Guideline “ Ascites, spontaneous bacterial peritonitis, hepatorenal syndrome ”

  year unknowncites this paper